Furthermore, in agreement with the hypothesis that HELU may represent the biological precursor of ADH to be used for the early assessment of breast cancer risk, we compared the gene expression profile of HELU with that of a series of putative invasive breast cancer precursors, namely ADH and DCIS, and corresponding patient-matched, histologically normal tissue. This evidence concerns the gene AVP and ductal breast carcinoma in situ.